Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:36 pm Purchase | 2025-12-23 | 13G | Century Therapeutics, Inc. IPSC | Point72 Asset Management, L.P. | 5,961,563 6.800% | 1,235,924 (+26.15%) | Filing History |
| 2026-01-16 4:34 pm Purchase | 2026-01-09 | 13G | Century Therapeutics, Inc. IPSC | RA Capital Management, L.P. | 17,944,649 9.900% | 17,944,649 (New Position) | Filing History |
| 2026-01-16 4:32 pm Purchase | 2026-01-09 | 13G | Century Therapeutics, Inc. IPSC | Venrock Healthcare Capital Partners III, L.P. | 13,043,478 7.100% | 9,086,292 (+229.61%) | Filing History |
| 2026-01-16 4:23 pm Purchase | 2026-01-09 | 13G | Century Therapeutics, Inc. IPSC | Commodore Capital LP | 13,043,478 7.100% | 13,043,478 (New Position) | Filing History |
| 2026-01-15 4:19 pm Purchase | 2026-01-09 | 13G | Century Therapeutics, Inc. IPSC | TCG Crossover GP II, LLC | 17,754,430 9.900% | 17,754,430 (New Position) | Filing History |
| 2026-01-15 4:13 pm Purchase | 2026-01-08 | 13G | Century Therapeutics, Inc. IPSC | Deep Track Capital, LP | 13,486,400 7.340% | 13,486,400 (New Position) | Filing History |
| 2026-01-05 4:11 pm Purchase | 2025-12-23 | 13G | Century Therapeutics, Inc. IPSC | Point72 Asset Management, L.P. | 4,725,639 5.400% | 4,725,639 (New Position) | Filing History |
| 2025-11-14 4:30 pm Sale | 2025-09-30 | 13G | Century Therapeutics, Inc. IPSC | Bain Capital Life Sciences Opportunities III, LP | 3,538,609 4.100% | -1,781,722 (-33.49%) | Filing History |
| 2025-05-15 4:27 pm Sale | 2025-03-31 | 13G | Century Therapeutics, Inc. IPSC | CASDIN CAPITAL, LLC | 3,212,316 3.700% | -1,380,000 (-30.05%) | Filing History |
| 2025-02-14 6:14 pm Sale | 2024-12-31 | 13G | Century Therapeutics, Inc. IPSC | Venrock Healthcare Capital Partners III, L.P. | 3,957,186 4.700% | -1,432,073 (-26.57%) | Filing History |
| 2024-11-27 6:51 pm Purchase | 2024-11-20 | 13G | Century Therapeutics, Inc. IPSC | CASDIN CAPITAL, LLC | 4,592,316 5.400% | 1,380,000 (+42.96%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Century Therapeutics, Inc. IPSC | Venrock Healthcare Capital Partners III, L.P. | 5,389,259 6.400% | 1,984,126 (+58.27%) | Filing History |
| 2024-11-14 4:08 pm Sale | 2024-09-30 | 13G | Century Therapeutics, Inc. IPSC | CASDIN CAPITAL, LLC | 3,212,316 3.800% | -1,978,190 (-38.11%) | Filing History |
| 2024-11-12 09:55 am Sale | 2024-11-08 | 13G | Century Therapeutics, Inc. IPSC | FMR LLC | 2,521,511 2.976% | -1,091,040 (-30.20%) | Filing History |
| 2024-10-25 9:39 pm Purchase | 2024-10-10 | 13G | Century Therapeutics, Inc. IPSC | Boxer Capital Management LLC | 3,174,603 3.700% | 3,174,603 (New Position) | Filing History |
| 2024-04-25 4:48 pm Purchase | 2024-04-15 | 13G | Century Therapeutics, Inc. IPSC | Bain Capital Life Sciences Opportunities III, LP | 5,320,331 6.600% | 5,320,331 (New Position) | Filing History |
| 2024-04-22 7:24 pm Purchase | 2024-04-15 | 13G | Century Therapeutics, Inc. IPSC | Boxer Capital LLC | 4,901,603 5.800% | 4,901,603 (New Position) | Filing History |
| 2024-04-18 4:36 pm Purchase | 2024-04-11 | 13G | Century Therapeutics, Inc. IPSC | CASDIN CAPITAL, LLC | 5,190,506 6.080% | 1,984,126 (+61.88%) | Filing History |
| 2024-04-08 9:03 pm Sale | 2024-02-29 | 13D | Century Therapeutics, Inc. IPSC | CASDIN CAPITAL, LLC | 3,206,380 4.950% | -16,560 (-0.51%) | Filing History |
| 2024-03-04 4:16 pm Purchase | 2024-02-21 | 13G | Century Therapeutics, Inc. IPSC | Venrock Healthcare Capital Partners III, L.P. | 3,405,133 5.400% | 3,405,133 (New Position) | Filing History |